Two senior scientists say National Institutes of Health officials advised them to remove references to mRNA vaccines in grant ...

Fintel reports that on March 13, 2025, Citigroup initiated coverage of Moderna (NasdaqGS:MRNA) with a Neutral recommendation.

The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how ...

The truth about mRNA vaccines remains clouded in controversy as the fifth anniversary of the COVID-19 pandemic approaches, raising troubling questions about the narratives pushed by elite health ...

After hours: March 14 at 7:59:07 PM EDT Loading Chart for MRNA ...

mRESVIA is Moderna's second approved product in Canada, the first mRNA vaccine against RSV, and the only one in single-dose pre-filled syringes Canada is the fourth jurisdiction to approve mRESVIA ...

Shares in Moderna were ticking upwards today after ... that Merck has exercised an option in its collaboration with the mRNA vaccine specialist, first agreed in 2016 and expanded two years later ...

The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how ...

According to Pfizer and BioNTech, this is the first time that an mRNA-based flu vaccine has started a phase 3 efficacy trial. Its rival Moderna said earlier this month, however, that it has ...